Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Clinical validation studies of Neoral C(2) monitoring: a review.

× No keyword cloud information.

17 in total

1. Pharmacokinetic and pharmacodynamic analysis of cyclosporine A (CsA) to find the best single time point for the monitoring and adjusting of CsA dose using twice-daily 3-h intravenous infusions in allogeneic hematopoietic stem cell transplantation.

Authors: Tatsuo Furukawa; Tori Kurasaki-Ida; Masayoshi Masuko; Nobuhiro Tsukada; Kiyoshi Okazuka; Naoko Sato; Toshio Yano; Takashi Abe; Akihito Momoi; Yasuhiko Shibasaki; Masutaka Higashimura; Kaori Karimata; Masato Moriyama; Takashi Kuroha; Jun Takizawa; Ken Toba; Miwako Narita; Ichiro Fuse; Masuhiro Takahashi; Yoshifusa Aizawa
Journal: Int J Hematol Date: 2010-06-09 Impact factor: 2.490

2. Prediction of systemic exposure to cyclosporine in Japanese pediatric patients.

Authors: Toshiyuki Sakaeda; Kazumoto Iijima; Kandai Nozu; Tsutomu Nakamura; Yuka Moriya; Mika Nishikawa; Atsushi Wada; Noboru Okamura; Masafumi Matsuo; Katsuhiko Okumura
Journal: J Hum Genet Date: 2006-09-14 Impact factor: 3.172

3. Population pharmacokinetics of ciclosporin in haematopoietic allogeneic stem cell transplantation with emphasis on limited sampling strategy.

Authors: Abraham J Wilhelm; Peer de Graaf; Agnes I Veldkamp; Jeroen J W M Janssen; Peter C Huijgens; Eleonora L Swart
Journal: Br J Clin Pharmacol Date: 2012-04 Impact factor: 4.335

Clinical validation studies of Neoral C(2) monitoring: a review.

1. Pharmacokinetic and pharmacodynamic analysis of cyclosporine A (CsA) to find the best single time point for the monitoring and adjusting of CsA dose using twice-daily 3-h intravenous infusions in allogeneic hematopoietic stem cell transplantation.

2. Prediction of systemic exposure to cyclosporine in Japanese pediatric patients.

3. Population pharmacokinetics of ciclosporin in haematopoietic allogeneic stem cell transplantation with emphasis on limited sampling strategy.

4. Therapeutic monitoring of pediatric renal transplant patients with conversion to generic cyclosporin.

5. Cyclosporin therapeutic drug monitoring--an established service revisited.

6. Advantages of cyclosporin A using 2-h levels in pediatric kidney transplantation.

7. An economic model of 2-hour post-dose ciclosporin monitoring in renal transplantation.

8. Utility of C-2 (Cyclosporine) monitoring in postrenal transplant patients: A study in the Indian population.

9. Cyclosporine therapeutic monitoring with C(MAX) in kidney transplant recipients: racial considerations.

10. Cyclosporine absorption profiles in pediatric kidney and liver transplant patients.